January 02, 2020 at 05:11PM Postmarketing Studies and Clinical Trials—Implementation of Section 505(o)(3) of the Federal Food, Drug, and Cosmetic Act Guidance for Industry

Guidance for Industry - Drug Safety

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2SNnmw2